Novo Nordisk: Ugly Guidance, But Stock Refuses To Break Down Further (NYSE:NVO)
诺和诺德诺和诺德(US:NVO) Seeking Alpha·2026-02-10 23:33

行业动态 - 肥胖症药物市场正经历疯狂的波动 [1] 市场竞争 - 诺和诺德公司正面临来自主要竞争对手的挑战 这些对手旨在争夺其宝贵的市场份额 [1]

Novo Nordisk: Ugly Guidance, But Stock Refuses To Break Down Further (NYSE:NVO) - Reportify